Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology?

Item

http://www.wikidata.org/entity/Q36304013

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Alteration of radiotherapy fra ...... ier in head and neck oncology?

@ast

Alteration of radiotherapy fra ...... ier in head and neck oncology?

@en

type

Item

label

Alteration of radiotherapy fra ...... ier in head and neck oncology?

@ast

Alteration of radiotherapy fra ...... ier in head and neck oncology?

@en

prefLabel

Alteration of radiotherapy fra ...... ier in head and neck oncology?

@ast

Alteration of radiotherapy fra ...... ier in head and neck oncology?

@en

P1476

Alteration of radiotherapy fra ...... ier in head and neck oncology?

@en

P2093

Jacques Bernier

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis.

Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology.

An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer.

Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.

Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers.

Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiothera

Primary radiotherapy of squamous cell carcinoma of the oropharynx and pharyngolarynx: tentative multivariate modelling system to predict the radiocurability of neck nodes.

P304

305-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPONC0201

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16264988

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

chemotherapy